• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Meta-analysis effects of levosimendan on mortality and hemodynamics in patients with sepsis

    2023-11-23 09:47:58ZHAOMingruiZHENGRuiYANGYuanzheng
    Journal of Hainan Medical College 2023年13期
    關(guān)鍵詞:膿毒孟旦左西

    ZHAO Ming-rui, ZHENG Rui, YANG Yuan-zheng

    Emergency and Trauma College, Hainan Medical University, Haikou 571199, China

    Keywords:

    ABSTRACT Objective: To investigate the effect of levosimendan on 28-day mortality in patients with sepsis.Methods: The English databases including Embase, PubMed, Web of Science,Cochrane Library and Chinese databasesincluding China National Knowledge Infrastructure(NKI), Wan fang Data, VIP, CBM were searched with levosimendan, sepsis and septic shock is as search terms.The published clinical randomized controlled trials of levosimendan injection were searched and the primary outcome measures of 28-day and 30-day mortality were included.Secondary outcome measures were left ventricular ejection fraction, left ventricular work index, cardiac index, and lactic acid.The literature retrieved is from the establishment of the database to October 2022.Stata 14.0 software was used for all data consolidation,publication bias monitoring and sensitivity analysis.Results: A total of 15 studies with 1 337 patients were included in this meta-analysis.The results showed that at the 28-day mortality of patients with sepsis in the levosimendan group was not statistically superior to the 28-day mortality in the control group [RR=0.91, 95% CI(0.78~1.06), Z=1.24, P=0.22].However,levosimendan can increase left ventricular ejection fraction, decrease left ventricular function index, increase cardiac index and decrease lactic acid in patients with sepsis.Conclusion:There is insufficient evidence to support a reduction in 28-day mortality in sepsis patients with levosimendan.However, levosimendan showed positive results on hemodynamic parameters,and more clinical trials are needed to verify the application of levosimendan in hemodynamic parameters of sepsis.

    1.Introduction

    Sepsis is a disease in which infection leads to a systemic immune response that produces both pro-inflammatory and anti-inflammatory mechanisms, and coagulation interacts with the immune system and endothelium, resulting in impaired hemodynamics and ultimately multiple organ dysfunction[1].When inflammatory factors, including cytokines, nitric oxide, complement system and lipopolysaccharide (LSP), act on myocardial cells,cardiac function is inhibited[2].Septic cardiomyopathy SCM was first described in 1958, and it still lacks a clear and consistent definition.The most common definition is reversible myocardial dysfunction due to sepsis, characterized by LVFE< 50% as diagnostic criteria, left ventricular dilation, and early return to normal clinical status[3].In addition, it has been found that the activation of toll-like receptors (TLRS), nuclear factor KB,mitochondrial dysfunction, endothelial dysfunction, autonomic nervous regulation and other aspects are associated with sepsis cardiomyopathy (SCM), but the specific pathogenesis remains unclear[4].According to existing studies, septic cardiomyopathy can be defined as an acute syndrome of cardiac dysfunction associated with sepsis and unrelated to myocardial ischemia, but there is still a lack of clear diagnostic criteria and strict evidence-based medicine definition of septic cardiomyopathy[5].

    Levosimendan is calcium ion sensitizer, a new type of positive inotropic drugs.Compared with positive inotropic drugs,levosimendan does not increase the concentration of Ca2+in cardiomyocytes, but plays a strong role through the sensitivity of myocardial contractile proteins to Ca2+, so it is called calcium sensitizer[6].Therefore, levosimendan did not increase the influx of Ca2+in cardiomyocytes during excitatory systolic coupling, nor did it affect the diastolic function of myocardium due to the obstruction of outflow of Ca2+in cardiomyocytes due to the increase of intracellular Ca2+[7].Currently, it is widely used in acute heart failure patients with poor therapeutic effect of traditional positive inotropic drugs, and can also be used in the treatment of cardiogenic shock, pulmonary hypertension, perioperative cardiac surgery and other diseases.In the 2021 International Guidelines for the Management of Sepsis and Septic Shock, dobutamine is recommended to be added to norepinephrine and levosimendan is not recommended for patients with septic shock and cardiac insufficiency when volume and arterial pressure are sufficient.This recommendation is presented as weak and of low quality evidence [8].However, compared with dobutamine in the treatment of sepsis and septic shock, the improvement of mortality and cardiac function indicators is still controversial.A comparative study of levosimendan versus dobutamine or a blank control group was conducted to evaluate the clinical effect of levosimendan on 28-day mortality and hemodynamics.To provide reference for clinical treatment from the perspective of evidencebased medicine.

    2.Data and methods

    2.1 Selection of documents

    Inclusion criteria: (1) Subjects were >18 years old and diagnosed as meeting international or Chinese guidelines for the treatment of sepsis or septic shock;(2) no contraindications to levosimendan application; (2) Levosimendan was applied in the intervention group;The control group was other positive inotropic drugs or other blank controls.There is no dose schedule or time limit for infusion; (3)Study type: randomized controlled trial; (4) Report 28-day mortality or 30-day mortality data.

    Exclusion criteria: (1) duplication;(2) animal experiments or in vitro studies;(3) Patients with sepsis or septic shock were not clearly diagnosed;(4) Excluding the use of positive inotropic drugs or combined with adult drugs except levosimendan; (5) Conference articles and master and erudite papers.

    2.2 Literature retrieval strategy

    References were obtained from two researchers who independently searched the following databases: CNKI, Wanfang Data, VIP, China Biomedical Literature Database, Embase, PubMed, Web of Science,and Cochrane library.The search time was updated from the database to October 1, 2022.There are no language restrictions.In addition, references included in the study and related meta-analysis were tracked to supplement the relevant literature.The retrieved literature was imported into Noteexpress literature management software, and duplicates and non-randomized controlled studies were eliminated according to the title and abstract of the literature.Unable to judge the literature, further reading the full text of literature to screen out the literature meeting the inclusion criteria.Consult with the third researcher in case of inclusion disagreements.

    Search the above database by the combination of subject words and free words.Chinese search terms include:休克,膿毒性、膿毒癥、膿毒血癥、膿毒性休克、感染性休克、左西孟旦、隨機(jī)對(duì)照試驗(yàn)、隨機(jī)對(duì)照實(shí)驗(yàn)、隨機(jī)對(duì)照研究。English search terms include:Sepsis, Bloodstream Infection,Bloodstream Infections,Infection, Bloodstream, Pyemia, Simendan,Levosimendan, Randaomized controlled trialetc.

    2.3 Literature quality evaluation

    The included literature was assessed independently by two investigators using the Cochrane risk bias assessment tool.The evaluation included whether random allocation was used, whether the allocation scheme was hidden, whether blind, whether there was selective reporting of research results, and whether there were other sources of migration.

    2.4 data extraction

    The required data were extracted from the included literature: (1)basic literature information: first author and publication date;(2)Basic information of the subjects (age, gender, diagnosis and the number of experimental group and control group);(3) Intervention measures (drug name, dosage and duration of infusion used in experimental group and control group);(4) Outcome indicators:primary outcome indicators (28-day mortality or 30-day mortality),secondary outcome indicators (left ventricular ejection fraction, left ventricular work index, cardiac index, lactic acid).

    2.5 statistical method

    Stata MP 14 software was used for statistical analysis and forest map drawing.Relative risk (RR) and 95% confidence interval were used to represent the biclassification data.Continuity variables were represented by weighted mean difference (WMD) and 95%confidence interval (CI) Q test was used to test the heterogeneity of each study.IfI2of Q test is less than 50%, andP>0.1 of Q test,it is considered that all studies are homogeneous, and fixed-effect model is used for analysis.IfI2of Q test is greater than 50% andP<0.1, heterogeneity is considered in all studies, and random effects model is adopted for analysis[9].The Stata MP 14 software was used to determine whether publication bias existed in Egger’s linear regression quantitative detection and evaluation.IfP<0.05 suggested publication bias, shear and supplement method and single study examination were used for sensitivity analysis.IfP>0.05 indicates no significant publication bias, the results are reliable.

    3.Result

    3.1 Literature search results

    A total of 345 articles were obtained according to the search strategy.There were 172 duplicate literatures, 69 reviews and systematic reviews, 12 animal experiments, 7 conference papers and graduation papers, 73 literatures with inconsistent research content and experimental design were excluded, 3 literatures with inclusion criteria were obtained through other channels, and 15 literatures were finally included in the meta-analysis.A total of 1337 patients were enrolled, of which 672 were enrolled in the experimental group(levosimendan group) and 665 were enrolled in the control group(other positive inotropic agents or placebo) (Figure 1).The literature was evaluated according to the Cochrane risk Bias assessment tool(Figure 2).

    Both Roald Dahl s poem of the tale and Stephen Sondheim s musical, Into the Woods, have Red Riding Hood overcome the wolf and later appear wearing a fur coat made of the wolf s fur, instead of the identifying red cloak.

    Fig 1 Flow chart in literature inclusion

    3.2 Results of meta-analysis

    3.2.1 28-day mortality analysis

    Fifteen articles reported 28-day mortality rates between levosimendan and the control group, and two articles reported 30-day mortality rates.The results showed that the 28-day mortality of sepsis patients in the levosimendan group was not statistically superior to that in the control group (Fixed effect RR=0.91, 95%confidence interval [CI] [0.78-1.06],Z=1.24,P=0.22>0.05) (Figure 3, 4).

    Tab 1 Characteristics of included literature

    Fig 2 Quality assessment of the included literature

    3.2.2 Left ventricular ejection fraction (LVEF) analysis

    Left ventricular ejection fraction (LVEF) of levosimendan and control group was reported in 10 literatures.The results showed that the left ventricular ejection fraction of patients with sepsis in levosimendan group was statistically different from that in control group, and the intervention effect was significant.(Fixed effect WMD=5.328, 95% confidence interval [CI] [4.19-6.47],Z=9.17,P=0.000<0.05) (Figure 5).

    3.2.3 Left ventricular work index (LVSWI) analysis

    The left ventricular work index (LVSWI) of levosimendan and control group was reported in 4 literatures.The results showed that LVSWI in the treatment of sepsis patients in levosimendan group was statistically different from that in the control group, and the intervention effect was significant.(Random effects WMD=4.458,95% confidence interval [CI] [2.98-5.93],Z=5.92,P=0.000<0.05)(Figure 6).

    3.2.4 Cardiac index (CI) analysis

    Cardiac index (CI) of levosimendan and control group was reported in 7 literatures.The results showed that the CI of the levosimendan group in the treatment of sepsis patients was statistically significant compared with the control group.(Random effectsWMD=0.507, 95%confidence interval [CI] [0.33-0.68],Z=5.71,P=0.000<0.05) (Figure 7).

    3.2.5 Lactic acid (Lac) analysis

    Lactic acid results (Lac) of levosimendan and control group were reported in seven articles.According to the results of meta-analysis,Lac in the treatment of sepsis patients in levosimendan group was statistically different from that in the control group (fixed effectsWMD= 0.969, 95% confidence interval [CI] (1.23 ~ 0.71),Z= 7.27,P= 0.000 < 0.05) (figure 8).

    Fig 3 Forest map of 28-day mortality

    Fig 4 Funnel plot of 28-day mortality

    Fig 5 Forest map of left ventricular ejection fraction (LVEF)

    Fig 6 Forest map of left ventricular work index (LVSWI)

    3.3 Publication bias evaluation

    The publication bias of 15 articles included in the evaluation of the influence of levosimmondal on the 28-day mortality of sepsis patients was roughly symmetrical in the distribution of funnel plot scatter points, and the Egger’s test was used to quantitatively evaluate publication bias, andP=0.015<0.05 was obtained, indicating the existence of publication bias.The shear supplement method was further used to further test the publication bias.No virtual shear supplement literature or data was added to the corrected results by the shear supplement method.At the same time, a single study wasused to assess the impact of each included article on the 28-day mortality outcome, and the results showed that the combined association and inter-study heterogeneity after excluding any article had little effect on the total combined effect size, and the results were reliable and acceptable (Figure 9, 10).

    Fig 8 Forest map of lactic acid (Lac)

    To evaluate the bias of the results of 10 articles included in the secondary outcome index LVEF, the funnel plot scatter distribution was roughly symmetrical, and the Egger’s test was used to evaluate publication bias quantitatively, andP=0.814 > 0.05 was obtained,indicating a stable result (Figure 11).

    To evaluate the bias of the results of 7 articles included in the secondary outcome index CI, the funnel plot scatter distribution was roughly symmetrical, and the Egger’s test was used to evaluate publication bias quantitatively, andP=0.205 > 0.05 was obtained,indicating a stable result (Figure 12).

    To evaluate the bias of 7 articles included in Lac, the funnel plot scatter distribution was roughly symmetrical, and the Egger’s test was used to evaluate publication bias quantitatively, andP=0870 >0.05 was obtained, indicating a stable result.

    Fig 9 Correction chart of 28-day mortality by shear supplement method

    Fig 10 Impact assessment of a single study on 28-day mortality

    Fig 11 Egger’s test of LVEF

    Fig 12 Egger’s test of CI

    Fig 13 Egger’s test of Lac

    4.Discussion

    4.1 Effect of levosimendan injection on mortality

    In this study, 15 literatures with 28-day mortality or 30-day mortality as primary outcome indicators were included (all randomized controlled studies).A meta-analysis was used to conduct a comprehensive quantitative analysis of Levosimendan injection on mortality.There was no significant difference in mortality outcomes at 28 days between the treatment group (levosimendan) and the control group (conventional therapy or other positive inotropic drugs).Levosimendan showed no significant difference in the 28-day mortality of sepsis patients compared with the control group.The conclusion was consistent with the meta-analysis published by Fang Feng[25] et al in 2019 and Guo Qingqing[26] et al in 2021.Levosimendan could not reduce the mortality of sepsis patients,which was consistent with the conclusion of this study.However,In a meta-analysis by Zangrillo[27] et al., levosimendan was associated with significantly reduced mortality in patients with septic shock compared to standard positive inotropic drug therapy.Yang Chunbo[28]et al.found in a meta-analysis study on the clinical efficacy of patients with septic cardiomyopathy that levosimendan could reduce the mortality of patients with septic cardiomyopathy compared with dobutamine.The reasons for the different results may be that the included literature and research objects are different,and the statistical methods used are slightly different.Therefore,more prospective multi-center clinical studies are needed for further research to increase the evidence-based medical basis.

    In terms of the influence of levosimendan on hemodynamic indexes, the results showed that the left ventricular ejection fraction(LVEF), left ventricular work index (LVSWI), heart index (CI)and lactic acid (Lac) of sepsis patients had significant statistical differences compared with the control group.In other words,levosimendan can increase left ventricular ejection fraction, decrease left ventricular function index, increase cardiac index, and decrease lactic acid in sepsis patients compared with other positive inotropic drugs or conventional therapy.In 2010, Bergh et al.[29] conducted a randomized double-blind clinical study on patients with acute onset chronic heart failure, comparing levosimendan with dobutamine,and the results showed that the hemodynamic improvement in the levosimendan infusion group was due to dobutamine.In a prospective single-center study on the hemodynamics of levosimendan on end-stage stable heart failure, Emil et al.[30] found that levosimendan was associated with improved hemodynamics in study subjects.The above literature showed positive significance for the hemodynamic outcome of levosimendan in patients with heart failure.In addition, a retrospective study published by Hu Aihao[31] et al.in 2021 on the effects of levosimendan combined with recombinant human brain natriuretic peptide for injection on left heart function and hemodynamics in septic shock patients showed that levosimendan combined with recombinant human brain natriuretic peptide for injection could improve left heart function and hemodynamics in septic shock patients.Levosimendan has been poorly studied in the treatment of sepsis and septic shock, and still shows a positive advantage over other positive inotropic drugs in the published literature, which is consistent with the results of this study.However, more clinical data are needed for further and specific research results.

    Limitations of this meta-analysis: the sample size of most of the included articles was small, and the proportion of patients studied in one article accounted for one-third of the total number of Meta articles.This may lead to deviations between the final results and the actual clinical situation and experimental results.For the main outcome indicators, some studies used 28-day mortality, some used 30-day mortality, and different outcome indicators data may also have biases on the results of the study.In addition, the drugs used in the control group were different, including dobutamine, conventional treatment group and epinephrine.The types of drugs used, dosages and drip rates of drugs were different, which would also cause deviations in the results.Among the secondary outcome indicators,there were differences in the time of data collection and recording.The experimental data came from different time after enrollment,such as 24 h, 48 h and 72 h.Meanwhile, the number of studies and experiments that could be included in the secondary outcome indicators was small, which may lead to the deviation in the results.Therefore, more prospective multi-center clinical trials are needed to further improve the efficacy of levosimendan in patients with sepsis and septic shock.

    In summary, compared with dobutamine or conventional treatment,levosimendan could not reduce the mortality of sepsis patients,but could increase LVEF and CI, and decrease LVSWI and Lac.However, the sample size of this meta-analysis is insufficient and there is a lack of high-quality literature support.The conclusions obtained need more clinical data support, and should also be used with caution in clinical application.The application of levosimendan in septic cardiomyopathy still needs further exploration in the future.

    猜你喜歡
    膿毒孟旦左西
    MMP-9對(duì)急性呼吸窘迫綜合征并膿毒性休克患者的早期診斷及預(yù)后評(píng)估價(jià)值研究
    血清NGAL聯(lián)合乳酸及APACHE Ⅱ評(píng)分對(duì)膿毒性休克合并急性腎損傷患者病死的預(yù)測(cè)價(jià)值
    左西孟旦治療重癥冠心病所致心衰的臨床療效
    急性心肌梗死伴心力衰竭患者行左西孟旦治療的臨床療效
    左西孟旦聯(lián)合無(wú)創(chuàng)正壓通氣治療急性心肌梗死后急性左心衰竭的效果觀察
    β受體阻滯劑在膿毒性休克中的應(yīng)用研究進(jìn)展
    西替利嗪與左西替利嗪對(duì)大鼠氨茶堿血藥濃度的影響
    左西孟旦治療急性失代償性心力衰竭的效果評(píng)價(jià)
    中西醫(yī)結(jié)合治療糖尿病并發(fā)癰疽合膿毒敗血癥驗(yàn)案2則
    香蕉国产在线看| 搡老乐熟女国产| 成人黄色视频免费在线看| 欧美激情极品国产一区二区三区| 高清在线视频一区二区三区| 咕卡用的链子| 免费av中文字幕在线| 少妇人妻久久综合中文| 免费观看av网站的网址| 午夜福利乱码中文字幕| 久久久久国产精品人妻一区二区| 色播在线永久视频| 国产日韩一区二区三区精品不卡| 男的添女的下面高潮视频| 伦理电影大哥的女人| 一区二区日韩欧美中文字幕| 久久精品国产a三级三级三级| 韩国高清视频一区二区三区| 久久久久网色| 国产在视频线精品| 91精品伊人久久大香线蕉| 两个人看的免费小视频| 国产97色在线日韩免费| 这个男人来自地球电影免费观看 | 1024视频免费在线观看| 亚洲av电影在线进入| 十八禁网站网址无遮挡| 免费少妇av软件| 久久精品国产a三级三级三级| 欧美成人精品欧美一级黄| 老鸭窝网址在线观看| 伊人久久大香线蕉亚洲五| 精品久久久精品久久久| 国产精品女同一区二区软件| 成人影院久久| 大片电影免费在线观看免费| 日韩大片免费观看网站| 日本午夜av视频| 国产精品偷伦视频观看了| 亚洲一区二区三区欧美精品| 美女脱内裤让男人舔精品视频| 极品人妻少妇av视频| 人人妻人人澡人人爽人人夜夜| 蜜桃在线观看..| 成年动漫av网址| 久久精品aⅴ一区二区三区四区| 久久人人97超碰香蕉20202| 日韩一区二区三区影片| 亚洲精品国产av成人精品| 丰满迷人的少妇在线观看| 大码成人一级视频| 成人国产av品久久久| 欧美国产精品va在线观看不卡| 久久人人爽av亚洲精品天堂| 国产人伦9x9x在线观看| 日本猛色少妇xxxxx猛交久久| 各种免费的搞黄视频| 99热网站在线观看| 日本vs欧美在线观看视频| 99精品久久久久人妻精品| 青草久久国产| 91国产中文字幕| 大话2 男鬼变身卡| 大话2 男鬼变身卡| 丝袜美腿诱惑在线| 亚洲自偷自拍图片 自拍| 男人操女人黄网站| 国产精品无大码| 1024视频免费在线观看| 国产精品 国内视频| 久久99一区二区三区| 天堂中文最新版在线下载| 国产av精品麻豆| 夫妻性生交免费视频一级片| videosex国产| www.av在线官网国产| 欧美激情极品国产一区二区三区| 啦啦啦 在线观看视频| 午夜福利,免费看| 亚洲在久久综合| 中文字幕人妻丝袜一区二区 | 国产97色在线日韩免费| 女人精品久久久久毛片| 国产成人91sexporn| 各种免费的搞黄视频| 国产精品亚洲av一区麻豆 | 亚洲国产欧美日韩在线播放| 三上悠亚av全集在线观看| 如何舔出高潮| 免费看av在线观看网站| 亚洲精品国产区一区二| 热re99久久精品国产66热6| 亚洲精品在线美女| 飞空精品影院首页| 亚洲国产成人一精品久久久| 欧美亚洲日本最大视频资源| 国产精品蜜桃在线观看| 老司机靠b影院| 熟妇人妻不卡中文字幕| 日日啪夜夜爽| 少妇精品久久久久久久| 午夜影院在线不卡| 美女午夜性视频免费| 亚洲第一av免费看| 欧美精品高潮呻吟av久久| 十八禁高潮呻吟视频| 丁香六月天网| 高清在线视频一区二区三区| 伊人久久大香线蕉亚洲五| 久久精品国产a三级三级三级| 极品少妇高潮喷水抽搐| 在线观看人妻少妇| av在线老鸭窝| 天天影视国产精品| 亚洲国产看品久久| 国产精品香港三级国产av潘金莲 | 中文字幕制服av| 亚洲精品一区蜜桃| 精品亚洲成a人片在线观看| 狠狠精品人妻久久久久久综合| 男人舔女人的私密视频| 免费黄网站久久成人精品| 日韩制服丝袜自拍偷拍| 久久人人97超碰香蕉20202| 涩涩av久久男人的天堂| 久久精品熟女亚洲av麻豆精品| 精品人妻在线不人妻| 熟女av电影| 女人久久www免费人成看片| 黑丝袜美女国产一区| 在线看a的网站| 又大又爽又粗| 日本午夜av视频| 性少妇av在线| 成年女人毛片免费观看观看9 | 99九九在线精品视频| 一本大道久久a久久精品| 一本大道久久a久久精品| 下体分泌物呈黄色| 麻豆精品久久久久久蜜桃| 天堂俺去俺来也www色官网| 天天躁夜夜躁狠狠躁躁| 嫩草影视91久久| avwww免费| 考比视频在线观看| 精品少妇黑人巨大在线播放| 天天添夜夜摸| 日韩av不卡免费在线播放| 中文欧美无线码| 日韩不卡一区二区三区视频在线| 免费不卡黄色视频| 熟女少妇亚洲综合色aaa.| av天堂久久9| 国产精品女同一区二区软件| 国产免费一区二区三区四区乱码| 国产精品久久久久成人av| 国产亚洲av高清不卡| 飞空精品影院首页| 无遮挡黄片免费观看| 人妻 亚洲 视频| 19禁男女啪啪无遮挡网站| 叶爱在线成人免费视频播放| 天天操日日干夜夜撸| 免费久久久久久久精品成人欧美视频| 亚洲欧洲精品一区二区精品久久久 | av又黄又爽大尺度在线免费看| 日日撸夜夜添| 中文字幕最新亚洲高清| 啦啦啦在线免费观看视频4| 一区二区三区乱码不卡18| 色婷婷久久久亚洲欧美| 少妇人妻精品综合一区二区| 999精品在线视频| 久久精品国产a三级三级三级| 在线观看一区二区三区激情| 91精品三级在线观看| 天堂中文最新版在线下载| 丝袜人妻中文字幕| 色婷婷av一区二区三区视频| 一边亲一边摸免费视频| 伦理电影免费视频| 久久精品亚洲av国产电影网| 亚洲色图 男人天堂 中文字幕| 99精品久久久久人妻精品| 精品午夜福利在线看| 国产一区二区 视频在线| 亚洲欧美一区二区三区久久| 欧美国产精品va在线观看不卡| 亚洲精品成人av观看孕妇| 亚洲专区中文字幕在线 | 51午夜福利影视在线观看| 亚洲精品日韩在线中文字幕| 亚洲av成人精品一二三区| 男女边吃奶边做爰视频| 卡戴珊不雅视频在线播放| 日本欧美国产在线视频| 欧美 日韩 精品 国产| 免费少妇av软件| 久久鲁丝午夜福利片| 伊人亚洲综合成人网| 成人黄色视频免费在线看| 日韩中文字幕视频在线看片| 日韩成人av中文字幕在线观看| 女性被躁到高潮视频| 免费看av在线观看网站| 精品一区二区三卡| 亚洲男人天堂网一区| 99国产综合亚洲精品| 亚洲人成电影观看| 国产精品人妻久久久影院| 日日摸夜夜添夜夜爱| 麻豆乱淫一区二区| 乱人伦中国视频| a级片在线免费高清观看视频| 国产精品一区二区在线观看99| 视频在线观看一区二区三区| 少妇人妻久久综合中文| 亚洲国产精品一区三区| 下体分泌物呈黄色| 国产精品久久久av美女十八| 国产精品二区激情视频| 国产福利在线免费观看视频| 99热国产这里只有精品6| 亚洲国产中文字幕在线视频| 欧美乱码精品一区二区三区| 999久久久国产精品视频| 赤兔流量卡办理| 精品免费久久久久久久清纯 | 亚洲国产成人一精品久久久| 午夜福利乱码中文字幕| 亚洲中文av在线| 亚洲激情五月婷婷啪啪| av片东京热男人的天堂| 男女高潮啪啪啪动态图| 无限看片的www在线观看| 日韩一本色道免费dvd| 亚洲国产精品一区二区三区在线| 人人妻人人澡人人爽人人夜夜| 高清欧美精品videossex| 日韩制服骚丝袜av| 久久久久久久久久久免费av| 一级毛片我不卡| 免费不卡黄色视频| 最近最新中文字幕大全免费视频 | 国产亚洲精品第一综合不卡| 欧美 亚洲 国产 日韩一| 香蕉丝袜av| 美女国产高潮福利片在线看| 国产亚洲午夜精品一区二区久久| 色网站视频免费| 日韩精品免费视频一区二区三区| 如何舔出高潮| a级毛片黄视频| 色视频在线一区二区三区| 极品人妻少妇av视频| 精品国产一区二区三区久久久樱花| 国产日韩欧美在线精品| 建设人人有责人人尽责人人享有的| 日本av手机在线免费观看| 街头女战士在线观看网站| 黑丝袜美女国产一区| 久久久国产欧美日韩av| 少妇 在线观看| 日本av手机在线免费观看| 桃花免费在线播放| 97在线人人人人妻| 精品福利永久在线观看| 国产一区二区三区综合在线观看| 国产精品国产三级国产专区5o| 啦啦啦在线免费观看视频4| 久久午夜综合久久蜜桃| 美女主播在线视频| 成年美女黄网站色视频大全免费| 国产精品久久久人人做人人爽| 欧美亚洲日本最大视频资源| 久久久久久免费高清国产稀缺| 女人爽到高潮嗷嗷叫在线视频| 亚洲,一卡二卡三卡| 色播在线永久视频| 色播在线永久视频| 亚洲国产欧美网| 亚洲国产欧美网| 人妻人人澡人人爽人人| 嫩草影院入口| 亚洲婷婷狠狠爱综合网| 亚洲,一卡二卡三卡| 啦啦啦中文免费视频观看日本| 国产日韩一区二区三区精品不卡| 国产一区二区 视频在线| 久久综合国产亚洲精品| 中文精品一卡2卡3卡4更新| 久久午夜综合久久蜜桃| 久久 成人 亚洲| 久久国产亚洲av麻豆专区| 亚洲婷婷狠狠爱综合网| 少妇猛男粗大的猛烈进出视频| 黄色毛片三级朝国网站| 老司机深夜福利视频在线观看 | 精品国产一区二区久久| 亚洲欧美成人综合另类久久久| 波多野结衣一区麻豆| e午夜精品久久久久久久| 最近最新中文字幕免费大全7| 777米奇影视久久| 国产人伦9x9x在线观看| 国产成人免费无遮挡视频| 一级毛片我不卡| 午夜激情av网站| 最近2019中文字幕mv第一页| 一边摸一边做爽爽视频免费| 亚洲精品成人av观看孕妇| 国产日韩欧美视频二区| 亚洲精品国产av蜜桃| 亚洲精品一区蜜桃| kizo精华| 国产成人精品在线电影| 老司机影院毛片| 日韩大码丰满熟妇| 亚洲国产av影院在线观看| 99热网站在线观看| 色综合欧美亚洲国产小说| 国产男人的电影天堂91| 大片电影免费在线观看免费| 2018国产大陆天天弄谢| 啦啦啦中文免费视频观看日本| 国产免费一区二区三区四区乱码| 精品国产国语对白av| av国产久精品久网站免费入址| av一本久久久久| 久久97久久精品| 好男人视频免费观看在线| www日本在线高清视频| 国产老妇伦熟女老妇高清| 欧美 日韩 精品 国产| 美女视频免费永久观看网站| 国产精品久久久久久久久免| 亚洲av综合色区一区| 国产无遮挡羞羞视频在线观看| 亚洲精品国产区一区二| 日日啪夜夜爽| 黄片小视频在线播放| www.av在线官网国产| 中文字幕人妻丝袜制服| 亚洲美女黄色视频免费看| 国产欧美日韩综合在线一区二区| 桃花免费在线播放| 国产精品免费大片| 我的亚洲天堂| 一边摸一边做爽爽视频免费| 精品亚洲乱码少妇综合久久| 天天躁狠狠躁夜夜躁狠狠躁| 免费黄频网站在线观看国产| 嫩草影视91久久| 一级爰片在线观看| 午夜免费观看性视频| 欧美激情高清一区二区三区 | 制服诱惑二区| 午夜激情久久久久久久| 热re99久久国产66热| 又黄又粗又硬又大视频| 黑人巨大精品欧美一区二区蜜桃| 蜜桃国产av成人99| 国产淫语在线视频| 亚洲国产精品一区二区三区在线| 日韩制服骚丝袜av| xxxhd国产人妻xxx| 免费在线观看视频国产中文字幕亚洲 | 十八禁网站网址无遮挡| 亚洲欧美一区二区三区黑人| 午夜av观看不卡| 亚洲国产av影院在线观看| 亚洲成人手机| 丰满饥渴人妻一区二区三| 欧美精品亚洲一区二区| 日韩 亚洲 欧美在线| 国产欧美日韩一区二区三区在线| 99久久人妻综合| 成年动漫av网址| 欧美激情极品国产一区二区三区| 国产免费福利视频在线观看| 欧美精品人与动牲交sv欧美| 国产成人欧美在线观看 | 少妇人妻久久综合中文| av国产精品久久久久影院| 女性被躁到高潮视频| 亚洲,欧美精品.| 超色免费av| 熟女少妇亚洲综合色aaa.| 精品少妇一区二区三区视频日本电影 | 日韩成人av中文字幕在线观看| 亚洲精品国产av蜜桃| av.在线天堂| 久久久久久久久免费视频了| 999精品在线视频| 捣出白浆h1v1| 久久精品久久久久久噜噜老黄| av天堂久久9| 高清在线视频一区二区三区| 欧美xxⅹ黑人| 99久国产av精品国产电影| 欧美日韩精品网址| 三上悠亚av全集在线观看| 在线观看人妻少妇| 日韩视频在线欧美| 丝瓜视频免费看黄片| 日韩一卡2卡3卡4卡2021年| 1024视频免费在线观看| 成人午夜精彩视频在线观看| 在线免费观看不下载黄p国产| 久久久久精品性色| 悠悠久久av| 日韩精品免费视频一区二区三区| bbb黄色大片| 亚洲精品国产av成人精品| 亚洲国产精品国产精品| 亚洲,欧美精品.| 欧美日韩一级在线毛片| 欧美乱码精品一区二区三区| 亚洲男人天堂网一区| 又大又黄又爽视频免费| 中文字幕精品免费在线观看视频| 搡老岳熟女国产| 国产有黄有色有爽视频| 国产精品一区二区在线不卡| 国产爽快片一区二区三区| 中文字幕人妻丝袜制服| av在线播放精品| 在线观看人妻少妇| 中文天堂在线官网| 久久午夜综合久久蜜桃| 亚洲av成人不卡在线观看播放网 | 亚洲,欧美,日韩| bbb黄色大片| 国产在视频线精品| 亚洲欧美成人精品一区二区| 别揉我奶头~嗯~啊~动态视频 | 日韩视频在线欧美| 日本一区二区免费在线视频| av不卡在线播放| av视频免费观看在线观看| 99香蕉大伊视频| 欧美 亚洲 国产 日韩一| 搡老岳熟女国产| 久久99精品国语久久久| av在线播放精品| 国产一区有黄有色的免费视频| 婷婷色麻豆天堂久久| 久久久久久久精品精品| 国产日韩欧美亚洲二区| 亚洲av欧美aⅴ国产| xxxhd国产人妻xxx| 久久久精品免费免费高清| 日本av免费视频播放| a 毛片基地| 午夜福利免费观看在线| 99久久精品国产亚洲精品| 亚洲国产av影院在线观看| 最近2019中文字幕mv第一页| 午夜福利,免费看| 亚洲美女视频黄频| 下体分泌物呈黄色| 国产一区二区三区综合在线观看| 亚洲美女视频黄频| 亚洲精品在线美女| 一级毛片黄色毛片免费观看视频| 夫妻午夜视频| 女人被躁到高潮嗷嗷叫费观| 精品福利永久在线观看| 天天躁日日躁夜夜躁夜夜| 欧美在线黄色| 欧美亚洲 丝袜 人妻 在线| 国产精品99久久99久久久不卡 | 国产精品一国产av| 狂野欧美激情性bbbbbb| 国产成人精品在线电影| 久久久久人妻精品一区果冻| 久久久久久人人人人人| 亚洲精品,欧美精品| 老司机深夜福利视频在线观看 | 人妻一区二区av| 99热国产这里只有精品6| 热re99久久精品国产66热6| 叶爱在线成人免费视频播放| 久久热在线av| 免费黄频网站在线观看国产| 老司机影院成人| 午夜福利,免费看| 久久久久国产一级毛片高清牌| 亚洲精品成人av观看孕妇| 狠狠婷婷综合久久久久久88av| 丰满少妇做爰视频| 午夜福利,免费看| 欧美日韩亚洲国产一区二区在线观看 | 一级毛片电影观看| 我要看黄色一级片免费的| 亚洲成人免费av在线播放| 国产精品久久久久久人妻精品电影 | 午夜福利一区二区在线看| 日本一区二区免费在线视频| 亚洲精品国产区一区二| 国产av一区二区精品久久| 大码成人一级视频| 在线亚洲精品国产二区图片欧美| 国产av精品麻豆| 午夜日韩欧美国产| 国产成人午夜福利电影在线观看| 国产精品亚洲av一区麻豆 | 91成人精品电影| 最新的欧美精品一区二区| av卡一久久| 国产av一区二区精品久久| 男女边吃奶边做爰视频| 国产精品久久久久久久久免| 日韩人妻精品一区2区三区| 久久综合国产亚洲精品| 国产精品久久久av美女十八| 国产 一区精品| 不卡av一区二区三区| 亚洲男人天堂网一区| 亚洲精品国产色婷婷电影| 女人高潮潮喷娇喘18禁视频| av在线观看视频网站免费| 国产免费一区二区三区四区乱码| 蜜桃国产av成人99| 中文字幕人妻熟女乱码| 国产精品一区二区在线不卡| 天天躁狠狠躁夜夜躁狠狠躁| 如日韩欧美国产精品一区二区三区| 亚洲欧美清纯卡通| 捣出白浆h1v1| 激情五月婷婷亚洲| 男女午夜视频在线观看| 日本色播在线视频| 亚洲成人一二三区av| 国产女主播在线喷水免费视频网站| av卡一久久| 成人亚洲精品一区在线观看| 国产亚洲午夜精品一区二区久久| 日韩 欧美 亚洲 中文字幕| 国产精品秋霞免费鲁丝片| 妹子高潮喷水视频| 国产熟女午夜一区二区三区| 五月天丁香电影| 成人亚洲精品一区在线观看| √禁漫天堂资源中文www| 精品视频人人做人人爽| 国产成人免费观看mmmm| 一级a爱视频在线免费观看| 美女脱内裤让男人舔精品视频| 免费观看性生交大片5| 亚洲精华国产精华液的使用体验| 啦啦啦在线观看免费高清www| 熟妇人妻不卡中文字幕| av在线观看视频网站免费| 不卡av一区二区三区| 久久国产精品大桥未久av| 最近中文字幕高清免费大全6| 欧美变态另类bdsm刘玥| 国产一区亚洲一区在线观看| 三上悠亚av全集在线观看| 亚洲精品日韩在线中文字幕| av电影中文网址| a级片在线免费高清观看视频| 少妇的丰满在线观看| 国产爽快片一区二区三区| 91国产中文字幕| 午夜激情av网站| 国产男女超爽视频在线观看| 在线观看国产h片| 天天影视国产精品| 亚洲免费av在线视频| 亚洲第一av免费看| 色吧在线观看| 亚洲精品中文字幕在线视频| 天天添夜夜摸| 国产高清国产精品国产三级| 精品国产一区二区三区四区第35| 亚洲欧洲国产日韩| 国产成人欧美| 欧美日韩成人在线一区二区| 性色av一级| 亚洲一区二区三区欧美精品| 天天躁日日躁夜夜躁夜夜| 国产免费现黄频在线看| 嫩草影院入口| 久久久久精品人妻al黑| 青春草亚洲视频在线观看| 高清在线视频一区二区三区| 亚洲成国产人片在线观看| 新久久久久国产一级毛片| 日本午夜av视频| 久久久精品区二区三区| 欧美在线一区亚洲| 国产精品免费视频内射| 国产在线视频一区二区| av天堂久久9| 亚洲精品久久成人aⅴ小说| 成年女人毛片免费观看观看9 | 久久久久精品人妻al黑| √禁漫天堂资源中文www| 无遮挡黄片免费观看| 成年女人毛片免费观看观看9 | 成人漫画全彩无遮挡| 国产成人精品福利久久| 人人澡人人妻人| 精品人妻在线不人妻| 最新在线观看一区二区三区 | 美女主播在线视频| 另类精品久久| 男女下面插进去视频免费观看| 欧美久久黑人一区二区| 考比视频在线观看| xxx大片免费视频| 国产无遮挡羞羞视频在线观看| 亚洲天堂av无毛|